patent/JP-2002506865-A

Predicate	Object
classificationCPCInventive	http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D405-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4525 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-24 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
classificationIPCInventive	http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4525 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-24 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D405-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-443
filingDate	1999-03-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate	2002-03-05-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber	JP-2002506865-A
titleOfInvention	Crystal form of paroxetine
abstract	(57) [Summary]nPure, solvent-free, for example, crystalline paroxetine free base; and its use in therapy to treat depression.
isCitedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2009545593-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2014077023-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2002519422-A
priorityDate	1998-03-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type	http://data.epo.org/linked-data/def/patent/Publication

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID452651457 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9800501 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419507641 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID43815 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9845306 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID452451409

Total number of triples: 25.